{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:27:44Z","timestamp":1777865264198,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"am","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"US Government National Institutes of Health","doi-asserted-by":"publisher","award":["HL071818"],"award-info":[{"award-number":["HL071818"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"US Government National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA023168"],"award-info":[{"award-number":["P30CA023168"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006377","name":"Purdue University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001377","name":"Walther Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001377","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ejmech.2024.117024","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T01:31:25Z","timestamp":1731029485000},"page":"117024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Design, synthesis, and X-ray structural studies of a series of highly potent, selective, and drug-like G protein-coupled receptor kinase 5 inhibitors"],"prefix":"10.1016","volume":"282","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2472-1841","authenticated-orcid":false,"given":"Arun K.","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjith Kumar","family":"Gadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amol","family":"Sonawane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandali Piladuwa","family":"Gamage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JohnJ.G.","family":"Tesmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.117024_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tips.2017.11.009","article-title":"Subcellular organization of GPCR signaling","volume":"39","author":"Eichel","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2024.117024_bib2","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1152\/physrev.00003.2005","article-title":"Mammalian G proteins and their cell type specific functions","volume":"85","author":"Wettschureck","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2024.117024_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2011.08.001","article-title":"G protein-coupled receptor kinases: more than just kinases and not only for GPCRs","volume":"133","author":"Gurevich","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2024.117024_bib4","article-title":"\u03b2-Arrestins and G Protein-Coupled receptor trafficking","volume":"vol. 219","author":"Tian","year":"2014"},{"key":"10.1016\/j.ejmech.2024.117024_bib5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/CIRCRESAHA.118.311403","article-title":"G-Protein-Coupled receptors in heart disease","volume":"123","author":"Wang","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmech.2024.117024_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/415206a","article-title":"Seven-transmembrane-spanning receptors and heart function","volume":"415","author":"Rockman","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.117024_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033806","article-title":"The origin and evolution of G protein-coupled receptor kinases","volume":"7","author":"Mushegian","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.117024_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-2187-9-1","article-title":"Multiple functions of G protein-coupled receptor kinases","volume":"9","author":"Watari","year":"2014","journal-title":"J. Mol. Signal."},{"key":"10.1016\/j.ejmech.2024.117024_bib9","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bbamem.2006.09.019","article-title":"The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling","volume":"1768","author":"Ribas","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2024.117024_bib10","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood-2009-09-243980","article-title":"Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6","volume":"115","author":"Tiedemann","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2024.117024_bib11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/jamacardio.2015.0354","article-title":"How hypertrophic cardiomyopathy became a contemporary treatable genetic disease with low mortality: shaped by 50 years of clinical research and practice","volume":"1","author":"Maron","year":"2016","journal-title":"JAMA cardiology"},{"key":"10.1016\/j.ejmech.2024.117024_bib12","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3389\/fphar.2018.00904","article-title":"New insights in cardiac \u03b2-adrenergic signaling during heart failure and aging","volume":"9","author":"Lucia","year":"2018","journal-title":"Front. pharmacolog"},{"key":"10.1016\/j.ejmech.2024.117024_bib13","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1161\/CIRCRESAHA.112.273367","article-title":"Determining the absolute requirement of g protein\u2013coupled receptor kinase 5 for pathological cardiac hypertrophy","volume":"111","author":"Gold","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmech.2024.117024_bib14","doi-asserted-by":"crossref","first-page":"10169","DOI":"10.1128\/MCB.24.23.10169-10179.2004","article-title":"G protein-coupled receptor kinase 5 contains a DNA-binding nuclear localization sequence","volume":"24","author":"Johnson","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2024.117024_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057324","article-title":"Nuclear translocation of cardiac G Protein-Coupled Receptor kinase 5 downstream of select Gq-activating hypertrophic ligands is a calmodulin-dependent process","volume":"8","author":"Gold","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.117024_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41419-018-0299-1","article-title":"GRK5 functions as an oncogenic factor in non-small-cell lung cancer","volume":"9","author":"Jiang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2024.117024_bib17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.juro.2011.09.049","article-title":"G-protein coupled receptor kinase 5 regulates prostate tumor growth","volume":"187","author":"Kim","year":"2012","journal-title":"J. Urol."},{"key":"10.1016\/j.ejmech.2024.117024_bib18","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1158\/0008-5472.CAN-13-2708","article-title":"G protein\u2013coupled receptor kinase GRK5 phosphorylates moesin and regulates metastasis in prostate cancer","volume":"74","author":"Chakraborty","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2024.117024_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2021.105890","article-title":"Protein expression and purification of G-protein coupled receptor kinase 6 (GRK6), toward structure-based drug design and discovery for multiple myeloma","volume":"185","author":"Olson","year":"2021","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ejmech.2024.117024_bib20","first-page":"4253","article-title":"Down-regulated G protein-coupled receptor kinase 6 leads to apoptosis in multiple myeloma MM1R cells","volume":"16","author":"Zhang","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejmech.2024.117024_bib21","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1038\/s41467-022-32033-5","article-title":"Decoding kinase-adverse event associations for small molecule kinase inhibitors","volume":"13","author":"Gong","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.117024_bib22","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"Davis","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2024.117024_bib23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tips.2015.04.005","article-title":"FDA-approved small-molecule kinase inhibitors","volume":"36","author":"Wu","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2024.117024_bib24","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1021\/acs.jmedchem.1c00963","article-title":"Small molecule kinase inhibitor drugs (1995-2021): medical indication, pharmacology, and synthesis","volume":"65","author":"Ayala-Aguilera","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117024_bib25","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41573-021-00195-4","article-title":"Kinase drug discovery 20 years after imatinib: progress and future directions","volume":"20","author":"Cohen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.117024_bib26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/11318860-000000000-00000","article-title":"Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies","volume":"23","author":"Papaetis","year":"2009","journal-title":"BioDrugs"},{"key":"10.1016\/j.ejmech.2024.117024_bib27","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2006.06.3602","article-title":"Sunitinib: from rational design to clinical efficacy","volume":"25","author":"Chow","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2024.117024_bib28","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1021\/acs.jmedchem.0c01522","article-title":"Generation of highly selective, potent, and covalent G protein-coupled receptor kinase 5 inhibitors","volume":"64","author":"Rowlands","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117024_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115931","article-title":"Development of a new class of potent and highly selective G protein-coupled receptor kinase 5 inhibitors and structural insight from crystal structures of inhibitor complexes","volume":"264","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117024_bib30","doi-asserted-by":"crossref","first-page":"11129","DOI":"10.1021\/acs.jmedchem.1c00506","article-title":"Design, synthesis, and characterization of 4-aminoquinazolines as potent inhibitors of the G protein-coupled receptor kinase 6 (GRK6) for the treatment of multiple myeloma","volume":"64","author":"Uehling","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117024_bib31","doi-asserted-by":"crossref","first-page":"17184","DOI":"10.1021\/acs.jmedchem.1c01184","article-title":"Discovery of (Z)-1-(3-((1 H-Pyrrol-2-yl)methylene)-2-oxoindolin-6-yl)-3-(isoxazol-3-yl)urea derivatives as novel and orally highly effective CSF-1R inhibitors for potential colorectal cancer immunotherapy","volume":"64","author":"Lv","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117024_bib32","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2024.117024_bib33","first-page":"5879","article-title":"Overexpression of GRK6 associates with the progression and prognosis of colorectal carcinoma","volume":"15","author":"Tao","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejmech.2024.117024_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2019.105547","article-title":"Characterization of a hyperphosphorylated variant of G protein-coupled receptor kinase 5 expressed in E. coli","volume":"168","author":"Beyett","year":"2020","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ejmech.2024.117024_bib35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.molcel.2020.11.026","article-title":"Structure of a GRK5-calmodulin complex reveals molecular mechanism of GRK activation and substrate targeting","volume":"81","author":"Komolov","year":"2021","journal-title":"Mol. Cell."},{"key":"10.1016\/j.ejmech.2024.117024_bib36","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41586-023-06395-9","article-title":"GPCR activation and GRK2 assembly by a biased intracellular agonist","volume":"620","author":"Duan","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.117024_bib37","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1021\/acs.jmedchem.7b00112","article-title":"Structure-based design of highly selective and potent G protein-coupled receptor kinase 2 inhibitors based on paroxetine. Journal of medicinal chemistry","volume":"60","author":"Waldschmidt","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117024_bib38","doi-asserted-by":"crossref","first-page":"16785","DOI":"10.1074\/jbc.M601327200","article-title":"The structure of G protein-coupled receptor kinase (GRK)-6 defines a second lineage of GRKs","volume":"281","author":"Lodowski","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.117024_bib39","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1124\/mol.119.118661","article-title":"A new paroxetine-based GRK2 inhibitor reduces internalization of the \u03bc-opioid receptor","volume":"97","author":"Bouley","year":"2020","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117024_bib40","first-page":"2126","article-title":"model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.ejmech.2024.117024_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2024.117024_bib42","author":"Schr\u00f6dinger","year":"2020"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424009061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424009061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:07:14Z","timestamp":1777529234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424009061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":42,"alternative-id":["S0223523424009061"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117024","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and X-ray structural studies of a series of highly potent, selective, and drug-like G protein-coupled receptor kinase 5 inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117024"}}